Annual Report 2014 : Cancer can't match our resolve
Could proton therapy be the ‘holy grail’ for head and neck cancer treatments?
The good news is death rates continue to decline for the most common types of cancer, including lung, colon, breast and prostate.
Steven Frank, medical director of MD Anderson’s Proton Therapy Center, is seeing success in treating oropharyngeal cancer patients with intensity modulated proton therapy. The approach spares healthy tissue surrounding the tumor and reduces side effects. Photo: Eric Kayne
The bad news is a far less common head and neck cancer is rising sharply. Since the late 1980s, cases of oropharyngeal cancers that attack the back of the throat, the base of the tongue and the tonsils have jumped 225%. According to the Centers for Disease Control and Prevention, almost three-fourths of the cases are linked to HPV, the human papillomavirus.
“Smoking and alcohol were the main causes of oropharyngeal cancers prior to this millenium, but HPV infections linked to the sexual revolution are now causing most of these cancers,” says Steven Frank, M.D., associate professor of Radiation Oncology.
Even when diagnosed in late stage, most oropharyngeal cancers can be cured. But the radiation therapy traditionally used to treat head and neck cancers can cause debilitating side effects, including mouth and gum ulcers, difficulty swallowing, loss of appetite and the need for feeding tubes and hospitalization.
“Radiation destroys the cancerous cells,” Frank explains, “but it also destroys healthy cells, which can cause painful and difficult side effects.”
In 2010, MD Anderson’s Proton Therapy Center, where Frank serves as medical director, became the first site in North America to treat patients with intensity modulated proton therapy (IMPT). The technique uses an intricate network of magnets to aim a narrow proton beam at a tumor and “paint” the radiation dose onto it layer by layer. Healthy tissue surrounding the tumor is spared, and side effects are reduced.
A small but promising study conducted by MD Anderson last year showed that oropharyngeal cancer patients treated with IMPT needed feeding tubes only half as often as patients treated with standard radiation therapy. The study also showed that toxicity levels were dramatically lower in IMPT patients compared to patients treated with standard therapy.
A second MD Anderson study treated 15 head and neck cancer patients with an advanced form of IMPT, known as multi-field optimization intensity modulated proton therapy (MFO-IMPT). The treatment maps the location, size and dimensions of hard-to-reach, complicated tumors, then sends a potent dose of protons to attack the tumors in the “nooks and crannies” of the head and neck or skull base where they live, says Frank, the lead investigator of both studies.
Two years and four months after the study concluded, 93% of participants remained cancer free. During treatment, all reported that side effects were greatly reduced, prompting some radiologists to label IMPT the “holy grail” for head and neck cancers.
With these promising findings, MD Anderson, in collaboration with Massachusetts General Hospital’s Francis H. Burr Proton Therapy Center, has been awarded a $20 million grant from the National Institutes of Health to further study the role of IMPT in the treatment of head and neck cancers. The first randomized study has been opened to patients, with additional trials expected later this year.
More Stories From Annual Report
Improving survival with a new surgical protocol for ovarian cancer
Triathlete and marathoner Leslie Russell teaches reading to children with dyslexia in the Spring Branch Independent School District. It’s a job she loves in the community where she grew up.
Finding the least disruptive solution to get patients back on their feet
Tucked in the elbow crook of Louisiana’s eastern border with Mississippi lies the small town of Independence.
In early-stage breast cancer, a less aggressive approach can be just as effective
When treating women with breast cancer, less is sometimes more.
A childhood cancer survivor’s teenage worries? College and boys
Like many first-time parents, Gerardo and Dilma Camarillo worried when their 9-month-old daughter, Ivana, was running a fever. Pediatricians, friends and family reassured them.
Tiny clues left behind by cancer may help scientists solve its mystery
Tiny, virus-sized particles released by cancer cells may be the next big thing in the world of cancer biology. Exosomes, derived from cells and blood serum of patients, have been shown to detect pancreatic cancer and, possibly, breast cancer, and are also linked to increased cancer progression and tumor growth.
Grants fuel tomorrow’s cancer breakthroughs
A state of Texas program designed to expedite innovations in new cancer treatments has helped MD Anderson recruit several new faculty members during the past year.
Industry collaborations boost the immune system’s cancer-fighting abilities
MD Anderson’s expertise in cancer immunotherapy attracted the interest of four major pharmaceutical companies, which signed three-year collaborative agreements in early 2014 to develop new ways for the immune system to destroy tumors.
Developing a drug to starve cancer cells
The first experimental drug to be produced by MD Anderson’s drug discovery and development institute will kill cancer cells in a new way — by depriving them of the fuel necessary for growth and survival.
The road to recovery, minus the traffic
Marietta Cline is one busy woman. As a doctor with four children who loves to travel and build custom furniture, she’s a go-getter with little time to spare.
An exchange program brings the best to Brazil
As a youngster growing up in São Paulo, Diogo Bugano Diniz Gomes was fascinated by how things worked and how to fix them when they broke.
A call to action in South Texas
Since its introduction in the 1940s, the Pap test has been successfully detecting abnormal cells in the cervix that, if left untreated, could lead to cancer. In fact, that success has led to a 70% drop in cervical cancer rates in the United States.
The physician assistant will see you now
Jenny Dahl was within a semester of graduating with a nutrition degree when an invitation changed her mind — and her future.
The angelic side of Austin’s devilish taco king
The center that provides veterinary and preclinical research services to support MD Anderson has received new, leading-edge laboratory equipment, thanks to a $20,000 gift from Torchy’s Tacos in Austin.
With elevated risks, these survivors and ‘previvors’ aren’t taking any chances
When doctors told Mariana Torrado she had breast cancer, she didn’t believe them at first.
Solving baby boomers’ problem with hepatitis C
Baby boomers — Americans born between 1945 and 1965 — grew up in one of the wealthiest, most idealistic and physically fit generations in history.
Outreach delivers screening and hope to communities in need
More than 3,500 local women who are low income and uninsured have received free mammograms through an MD Anderson community outreach initiative.
A survivor is saving lives through early detection
It was 1980 when Janelle Hail of Frisco, Texas, discovered a small lump during a self-breast exam. A visit to the doctor resulted in an early breast cancer diagnosis. The then-34-year-old mother of three feared for her life. Today, she attributes her survival to early detection.
